Physician profile
Dinesh Telang
NPI 1265498117
$3,476.93
in general payments reported to CMS, 2019-2025
27 companies · $1,505 in 2025
The $1,505 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $51.80 · 2021: $344 · 2022: $755 · 2023: $376 · 2024: $262 · 2025: $1,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.72 |
| Travel and Lodging | $722.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,408.52 | 2021-2025 | Altaviva, Interstim |
| Axonics, INC. | $503.81 | 2021-2023 | Bulkamid, Axonics |
| Teleflex LLC | $156.11 | 2021-2022 | |
| Coloplast Corp | $134.85 | 2019-2024 | |
| Calyxo, INC. | $132.18 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $122.21 | 2019-2021 | |
| Cook Medical LLC | $119.54 | 2022 | |
| Boston Scientific Corporation | $118.65 | 2022-2025 | Rezum Generator, Axonics |
| C. R. Bard, INC. & Subsidiaries | $115.98 | 2024 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $95.62 | 2025 | |
| Karl Storz Endoscopy-America | $86.75 | 2023 | Hopkins, Autocon |
| Endo Pharmaceuticals INC. | $84.64 | 2021-2023 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $51.79 | 2019-2020 | |
| Ethicon US, LLC | $51.53 | 2019 | |
| Laborie Medical Technologies Corp. | $48.36 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $30.56 | 2021 | |
| Medtronic USA, INC. | $28.86 | 2019 | |
| Astellas Pharma US INC | $27.19 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $21.80 | 2023 | Orgovyx |
| Myovant Sciences INC. | $21.29 | 2022 | |
| Urogen Pharma, INC. | $19.15 | 2024 | |
| Myriad Genetic Laboratories, INC. | $18.26 | 2021 | |
| Abbvie INC. | $17.73 | 2023 | Lupron Depot |
| Foundation Medicine, INC. | $16.81 | 2023 | |
| Neotract INC. | $16.63 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $15.50 | 2019 | |
| Amgen INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Telang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.